Orchestra BioMed Holdings Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Orchestra BioMed Holdings stock has a consensus rating of "Strong Buy" and an average price target of $12.33. The average 1-year stock price forecast is 179.59% higher than the current stock price, while the lowest is $9.00 (+104.08%) and the highest is $20 (+353.51%).

Price Target: $12.33 (+179.59%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$9.00	$12.33	$10	$20
Change	+104.08%	+179.59%	+126.76%	+353.51%

Analyst Ratings

The average analyst rating for Orchestra BioMed Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	5	5	5	5	5	5
Buy	2	2	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yi Chen H.C. Wainwright	H.C. Wainwright	Buy Reiterates $10	Buy	Reiterates	$10	+126.76%	Aug 12, 2026
Matthew O'Brien Piper Sandler	Piper Sandler	Buy Reiterates $9 → $10	Buy	Reiterates	$9 → $10	+126.76%	Aug 11, 2026
Unknown Analyst BTIG No rating	BTIG	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Jul 9, 2026
Anderson Schock B. Riley Securities	B. Riley Securities	Buy Reiterates $12 → $10	Buy	Reiterates	$12 → $10	+126.76%	May 19, 2026
Matt Miksic Barclays	Barclays	Buy Reiterates $12 → $13	Buy	Reiterates	$12 → $13	+194.78%	May 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

445.86K

from 33.48M

-98.67%

from 33.48M

Revenue Next Year

572.86K

from 445.86K

28.48%

from 445.86K

EPS This Year

-1.52

from -1.11

EPS Next Year

-1.52

from -1.52

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-782.00K	3.53M	2.76M	2.64M	33.48M	445.86K
Revenue Growth	-	-	-21.88%	-4.42%	1,169.22%	-98.67%
Operating Income	-21.80M	-32.66M	-51.51M	-64.30M	-51.81M	-93.50M
Net Income	-23.01M	-33.61M	-49.12M	-61.02M	-52.70M	-96.75M
EPS	-	-	-	-	-1.11	-1.52
Free Cash Flow	-13.86M	-10.06M	-33.04M	-25.45M	-20.25M	-76.58M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	700,000
Avg	445,860
Low	363,000

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-97.9%
Avg	-98.7%
Low	-98.9%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-1.46
Avg	-1.52
Low	-1.65

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-